On 1 March 2022, the construction of Grizzly, a large and sustainable building on the Osse life sciences campus Pivot Park, will start. With an area of 11,000 m² spread over eight floors, Grizzly will act as a multi-tenant building. Organon is one of the first five tenants, along with Acerta Pharma, ImmunoPrecise Antibodies, NTRC and Oncolines.

Brigitte Drees, director of Pivot Park, is very happy that the construction of Grizzly can start. “The fact that we can start is mainly due to the five tenants. It’s great to see that they have every confidence in our plans and ambitions. All of these companies are already located at Pivot Park, but need more space than they currently have.”
If construction goes according to plan, Organon and the other tenants will be able to move into the building from October 2023. Upon completion, Grizzly (which is a working name) will also get its final name.